SlideShare una empresa de Scribd logo
1 de 8
Descargar para leer sin conexión
“Whilst every person carries millions of bacteria
     on their skin, hospitals should not be tolerant
     of any infections that could be avoided”
      The Public Accounts Committee, 10th November 20091




Prescribing information can be found on the back cover
“In most SSIs, the source of pathogens is the
 endogenous flora of the patient’s skin”2


SSIs are                    1 in 7 of all hospital-acquired infections are SSIs1
serious
                            SSIs require an average additional stay of 6.5 days
and costly
                            and hospital costs are doubled3

                            Patients with SSIs are 60% more likely to spend
                            time in ICU, 5 times more likely to be readmitted
                            to hospital and twice as likely to die4

                            Health-related quality of life may be significantly
                            impaired5




At one London Trust, the annual cost associated with
SSIs for just one surgical core area (coronary artery
bypass graft) amounted to around £500,0006


Surveillance programmes that rely only on inpatient data may hugely
underestimate the incidence and cost of SSIs7,8
ChloraPrep reduced SSIs by 41% compared
 with povidone iodine scrub and paint9

                   20
                                             p=0.004
Incidence
of SSIs in         15
clean-                          16.1
contaminated       10

surgery
                    5
                                                        9.5
(% patients)9

                    0

                             Povidone iodine           ChloraPrep
                                 n=440                   n=409



 ChloraPrep was significantly more protective against both superficial
 (52% reduction) and deep incisional infections (67% reduction):9

                   10
                                  p=0.008
Incidence
of incisional       8
infections
                           8.6
                    6
(% patients)9
                    4                                                     p=0.05
                                            4.2
                    2
                                                                    3.0            1.0
                    0

 Povidone iodine            Superficial incisional                   Deep incisional
 n=440                           infection                             infection
 ChloraPrep
 n=409




 The number needed to treat with ChloraPrep instead of povidone iodine in
 order to prevent one case of SSI was approximately 179
ChloraPrep was significantly more effective than
 0.5% chlorhexidine/70% isopropyl alcohol10


 Dressings removed 24 hours after saphenectomy contained a significantly
 lower number of micro-organisms with ChloraPrep10

                       20
Mean                               p=0.007

CFU counts             15
24 hours
                       10
                            14.8
after surgery10                                                             p=0.02
                        5
                                             0.6                  4.2                0.4
                        0

 0.5% chlorhexidine/         Adhesive dressing                        Absorbent dressing
 70% isopropyl                 component                                 component
 alcohol n=24
 ChloraPrep n=22



 Rates of SSI following saphenous vein harvest as high as 1 in 5 patients
 have been reported10

 At 30 days post-discharge, no ChloraPrep patient had developed
 an SSI following saphenectomy10
                       25
Incidence of                                  p=0.0502

superficial            20
SSI post-                          20.8
discharge              15
(% patients)10
                       10


                        5


                        0
                                                            0
                              0.5% chlorhexidine/        ChloraPrep
                             70% isopropyl alcohol         n=22
                                    n=24
ChloraPrep provides broad spectrum, rapid,
residual and persistent antimicrobial activity


ChloraPrep is effective against a broad range of micro-organisms
including MRSA, VRE, Clostridium difficile, coagulase negative
staphylococci and most viruses and fungi11-13



Optimal agent         ChloraPrep
for pre-surgical
skin antisepsis12


Rapid                                 ChloraPrep has good activity levels
                                      within 30 seconds;14 povidone
                                      iodine takes 2-3 minutes to reach
                                      full effect11




Persistent                            ChloraPrep is effective for at least
                                      48 hours.14,15 0.5% chlorhexidine13
                                      and iodophors have been shown
                                      to have a much shorter duration
                                      of activity16



Practical                             Unlike povidone iodine,
                                      ChloraPrep is not inactivated in
                                      the presence of blood12
ChloraPrep is an easy to apply, sterile,
skin antisepsis system


ChloraPrep is the only 2% chlorhexidine / 70% isopropyl
alcohol licensed for cutaneous antisepsis prior to invasive
procedures in the UK17



                               Sterile solution is maintained in a glass
                               ampoule prior to activation, obviating
                               concerns about contamination18


                               In line with ANTT™, the operator’s
                               hands do not come into contact with
                               the patient’s skin, preventing cross
                               contamination18


                               The foam sponge controls flow to
                               prevent splashing/pooling while gently
                               helping to expose bacteria in the lower
                               cell layers




A back and forth prep was used in all the phase III
efficacy studies of ChloraPrep applicators19
Using ChloraPrep surgical applicators



1. Pinch                                2. Apply                                   3. Dry




Pinch the lever to release the          Starting at the incision site,              Leave the area to dry
solution. You will hear a ‘pop’         gently press the applicator                 completely before applying
as the ampoule breaks.                  against the skin until the                  sterile drapes. Do not blot
                                        solution soaks the sponge.                  or wipe away. Discard the
                                                                                    applicator after a single use.
                                        Apply using repeated up and
                                        down, back and forth strokes                Important safety point:
                                        for at least 30 seconds, before             Do not drape or use ignition
                                        working outwards towards the                source until the solution has
                                        periphery.                                  completely dried.

                                        The 26ml applicator contains
                                        two swabs. Where applicable,
                                        the swabs can be moistened
                                        by pressing against the soaked
                                        sponge and then used to clean
                                        the umbilicus.




  References: 1. House of Commons Public Accounts Committee. Reducing Healthcare Associated Infection in
  Hospitals in England.10 November 2009. London: The Stationery Office Limited. 2. Murkin CE. Br J Nurs 2009; 18:
  665-9. 3. Edwards PS et al. Cochrane DB Syst Rev 2008. DOI:10.1002/14651858.CD003949.pub2. 4. Kirkland KB
  et al. Infect Control Hosp Epidemiol 1999; 20: 725-30. 5. Whitehouse JD et al. Infect Control Hosp Epidemiol 2002;
  23: 183-9. 6. Frampton L. Clin Services J 2008; June edition. 7. Tanner J et al. J Hosp Infect 2009; 72: 243-50.
  8. Ward VP et al. J Hosp Infect 2008; 70: 166-73. 9. Darouiche R et al. New Engl J Med 2010; 362: 18-26. 10. Casey
  AL et al. Poster presented at ECCMID, Barcelona, Spain, April 2008 11. Crosby CT, Mares AK. J Vasc Access Devices
  2001; Spring: 26-31. 12. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61 13. Data on file, CareFusion Ltd.
  14. Hibbard JS. J Infus Nurs 2005; 28: 194-207. 15. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002;
  Abs 418. 16. Fletcher N et al. J Bone Joint Surg Am 2007; 89: 1605-18. 17. UK PL 31760/0001. 18. McDonald CP.
  Vox Sanguinis 2001; 80: 135-41. 19. Richardson D. J Assoc Vasc Access 2006; 11: 215-21.
Range of surgical applicators
   Licensed, sterile, single use, ANTT™, latex free applicators available in the UK


                                          Coverage area: 15 cm x 15 cm
    3ml
                                          NHS list price per applicator: £0.85 (ex. VAT and delivery)
    clear
                                          NHS supply chain order code: MRB306



                                          Coverage area: 25 cm x 30 cm
   10.5ml
                                          NHS list price per applicator: £2.92 (ex. VAT and delivery)
    clear
                                          NHS supply chain order code: MRB304



                                          Coverage area: 50 cm x 50 cm
    26ml
                                          NHS list price per applicator: £6.50 (ex. VAT and delivery)
    clear
                                          NHS supply chain order code: MRB305



                                          Coverage area: 15 cm x 15 cm
    3ml
                                          NHS list price per applicator: £0.89 (ex. VAT and delivery)
   tinted
                                          NHS supply chain order code: MRB494



                                          Coverage area: 25 cm x 30 cm
   10.5ml
                                          NHS list price per applicator: £3.07 (ex. VAT and delivery)
    tinted
                                          NHS supply chain order code: MRB495



                                          Coverage area: 50 cm x 50 cm
   26ml
                                          NHS list price per applicator: £6.83 (ex. VAT and delivery)
   tinted
                                          NHS supply chain order code: MRB496


For customer services and all other enquiries:
Please telephone: 0800 0437 546
Email: enquiries@chloraprep.co.uk
or visit: www.chloraprep.co.uk

Prescribing Information                                                        only on intact skin. Avoid contact with eyes, mucous membranes, middle ear
ChloraPrep® (PL31760/0002) & ChloraPrep with Tint (PL31760-0001) 2%            and neural tissue. Should not be used in children under 2 months of age.
chlorhexidine gluconate w/v / 70% isopropyl alcohol v/v cutaneous solution.    Solution is flammable. Do not use with ignition sources until dry, do not allow
Indication: Disinfection of skin prior to invasive medical procedures.         to pool, and remove soaked materials before use. Over-vigorous use on
Dosage & administration: ChloraPrep – 0.67ml, 1.5ml, 3ml, 10.5ml, 26ml;        fragile or sensitive skin or repeated use may lead to local skin reactions. At
ChloraPrep with Tint – 3ml, 10.5ml, 26ml. Volume dependent on invasive         the first sign of local skin reaction, application should be stopped. Per
procedure being undertaken. Applicator squeezed to break ampoule and           applicator costs (ex VAT) ChloraPrep – 0.67ml (SEPP) - 30p; 1.5ml (FREPP)
release antiseptic solution onto sponge. Solution applied by gently pressing   - 55p; 3ml - 85p; 10.5ml - £2.92; 26ml - £6.50. ChloraPrep with Tint – 3ml -
sponge against skin and moving back and forth for 30 seconds. The area         89p; 10.5ml - £3.07; 26ml - £6.83. Legal category: GSL. Marketing
covered should be allowed to air dry. Side effects, precautions &              Authorisation Holder: CareFusion UK 244 Ltd, 43 London Road, Reigate,
contra-indications: Very rarely allergic or skin reactions reported with       Surrey RH2 9PW, UK. Date of preparation: July 2010.
chlorhexidine, isopropyl alcohol and Sunset Yellow. Contra-indicated for
patients with known hypersensitivity to these constituents. For external use   CHL104a Date of preparation: August 2010

Más contenido relacionado

Destacado

Proyectos_de_innovacion
Proyectos_de_innovacionProyectos_de_innovacion
Proyectos_de_innovacionWebMD
 
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - Planificación
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - PlanificaciónElaboración y Diseño de la Red de Impulsión de Servicios Básicos - Planificación
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - PlanificaciónDavid Salomon Rojas Llaullipoma
 
De Reis van de Heldin december 2015
De Reis van de Heldin december 2015De Reis van de Heldin december 2015
De Reis van de Heldin december 2015Peter de Kuster
 
Bpm en la elaboración de té instantáneo
Bpm en la elaboración de té instantáneoBpm en la elaboración de té instantáneo
Bpm en la elaboración de té instantáneoAlba Cabrera Urbieta
 
Wal Mart México 2009: lo barato sale caro
Wal Mart México 2009: lo barato sale caroWal Mart México 2009: lo barato sale caro
Wal Mart México 2009: lo barato sale caroPedro Guadiana
 
Error messages
Error messagesError messages
Error messagesrtinkelman
 
Gfpi f-019 guia de aprendizaje 01 tda orientar fpi
Gfpi f-019 guia de aprendizaje 01 tda orientar fpiGfpi f-019 guia de aprendizaje 01 tda orientar fpi
Gfpi f-019 guia de aprendizaje 01 tda orientar fpilisbet bravo
 
Análisis situacional integral de salud final
 Análisis situacional integral de salud final Análisis situacional integral de salud final
Análisis situacional integral de salud finalEstefanía Echeverría
 
JULIOPARI - Elaborando un Plan de Negocios
JULIOPARI - Elaborando un Plan de NegociosJULIOPARI - Elaborando un Plan de Negocios
JULIOPARI - Elaborando un Plan de NegociosJulio Pari
 
El emprendedor y el empresario profesional cert
El emprendedor y el empresario profesional certEl emprendedor y el empresario profesional cert
El emprendedor y el empresario profesional certMaestros Online
 
1ºBACH Economía Tema 5 Oferta y demanda
1ºBACH Economía Tema 5 Oferta y demanda1ºBACH Economía Tema 5 Oferta y demanda
1ºBACH Economía Tema 5 Oferta y demandaGeohistoria23
 
Analisis de la salud (asis)
Analisis de la salud (asis)Analisis de la salud (asis)
Analisis de la salud (asis)39307328
 
Onderzoeksrapport acrs v3.0_definitief
Onderzoeksrapport acrs v3.0_definitiefOnderzoeksrapport acrs v3.0_definitief
Onderzoeksrapport acrs v3.0_definitiefrloggen
 

Destacado (20)

Proyectos_de_innovacion
Proyectos_de_innovacionProyectos_de_innovacion
Proyectos_de_innovacion
 
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - Planificación
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - PlanificaciónElaboración y Diseño de la Red de Impulsión de Servicios Básicos - Planificación
Elaboración y Diseño de la Red de Impulsión de Servicios Básicos - Planificación
 
Relatietips
RelatietipsRelatietips
Relatietips
 
Componentes de un Plan de Negocios
Componentes de un Plan de NegociosComponentes de un Plan de Negocios
Componentes de un Plan de Negocios
 
De Reis van de Heldin december 2015
De Reis van de Heldin december 2015De Reis van de Heldin december 2015
De Reis van de Heldin december 2015
 
Bpm en la elaboración de té instantáneo
Bpm en la elaboración de té instantáneoBpm en la elaboración de té instantáneo
Bpm en la elaboración de té instantáneo
 
Wal Mart México 2009: lo barato sale caro
Wal Mart México 2009: lo barato sale caroWal Mart México 2009: lo barato sale caro
Wal Mart México 2009: lo barato sale caro
 
Error messages
Error messagesError messages
Error messages
 
Gfpi f-019 guia de aprendizaje 01 tda orientar fpi
Gfpi f-019 guia de aprendizaje 01 tda orientar fpiGfpi f-019 guia de aprendizaje 01 tda orientar fpi
Gfpi f-019 guia de aprendizaje 01 tda orientar fpi
 
Análisis situacional integral de salud final
 Análisis situacional integral de salud final Análisis situacional integral de salud final
Análisis situacional integral de salud final
 
Geheugen verbeteren
Geheugen verbeterenGeheugen verbeteren
Geheugen verbeteren
 
JULIOPARI - Elaborando un Plan de Negocios
JULIOPARI - Elaborando un Plan de NegociosJULIOPARI - Elaborando un Plan de Negocios
JULIOPARI - Elaborando un Plan de Negocios
 
Salud
SaludSalud
Salud
 
De impact van adhd
De impact van adhdDe impact van adhd
De impact van adhd
 
PMP Sonora Saludable 2010 2015
PMP Sonora Saludable 2010   2015  PMP Sonora Saludable 2010   2015
PMP Sonora Saludable 2010 2015
 
El emprendedor y el empresario profesional cert
El emprendedor y el empresario profesional certEl emprendedor y el empresario profesional cert
El emprendedor y el empresario profesional cert
 
1ºBACH Economía Tema 5 Oferta y demanda
1ºBACH Economía Tema 5 Oferta y demanda1ºBACH Economía Tema 5 Oferta y demanda
1ºBACH Economía Tema 5 Oferta y demanda
 
Tears In The Rain
Tears In The RainTears In The Rain
Tears In The Rain
 
Analisis de la salud (asis)
Analisis de la salud (asis)Analisis de la salud (asis)
Analisis de la salud (asis)
 
Onderzoeksrapport acrs v3.0_definitief
Onderzoeksrapport acrs v3.0_definitiefOnderzoeksrapport acrs v3.0_definitief
Onderzoeksrapport acrs v3.0_definitief
 

Similar a Surgical Leave Piece | ChloraPrep UK Infection Prevention & Control

Surgical Sales Aid | ChloraPrep UK Infection Prevention & Control
Surgical Sales Aid | ChloraPrep UK Infection Prevention & ControlSurgical Sales Aid | ChloraPrep UK Infection Prevention & Control
Surgical Sales Aid | ChloraPrep UK Infection Prevention & ControlChloraPrep UK
 
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & Control
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & ControlDarouiche Clinical Summary | ChloraPrep UK Infection Prevention & Control
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & ControlChloraPrep UK
 
Fumigation process and hospital infection control
Fumigation process and hospital infection controlFumigation process and hospital infection control
Fumigation process and hospital infection controlanjalatchi
 
Industrial Pharmacy I -Ophthalmic preparation part 1
 Industrial Pharmacy I -Ophthalmic preparation part 1 Industrial Pharmacy I -Ophthalmic preparation part 1
Industrial Pharmacy I -Ophthalmic preparation part 1SureshKumar3824
 
OP & OT sterilisation during COVID Times
OP & OT sterilisation during COVID TimesOP & OT sterilisation during COVID Times
OP & OT sterilisation during COVID TimesDevin Prabhakar
 
Materials for disinfecting the pulp space
Materials for disinfecting the pulp spaceMaterials for disinfecting the pulp space
Materials for disinfecting the pulp spaceParth Thakkar
 
Sterilisation ppt ashitha
Sterilisation ppt ashithaSterilisation ppt ashitha
Sterilisation ppt ashithaAshitha Dominic
 
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & Control
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & ControlMadeo Clinical Summary | ChloraPrep UK Infection Prevention & Control
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & ControlChloraPrep UK
 
Disinfectants- Pharmaceutical Microbiology
Disinfectants- Pharmaceutical MicrobiologyDisinfectants- Pharmaceutical Microbiology
Disinfectants- Pharmaceutical MicrobiologySanchit Dhankhar
 
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]drnahla
 
Surgical skin antiseptics
Surgical skin antisepticsSurgical skin antiseptics
Surgical skin antisepticsWafiMohammed
 
Sterilization_and_Disinfection.pptx
Sterilization_and_Disinfection.pptxSterilization_and_Disinfection.pptx
Sterilization_and_Disinfection.pptxPiaS13
 
Disinfection control in Prosthodontics
Disinfection control in ProsthodonticsDisinfection control in Prosthodontics
Disinfection control in ProsthodonticsDr Jibi Sara Varghese
 
ocular drug delivery system
ocular drug delivery systemocular drug delivery system
ocular drug delivery systemAnkur Verma
 
Vital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxVital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxGauriSShrestha
 

Similar a Surgical Leave Piece | ChloraPrep UK Infection Prevention & Control (20)

Surgical Sales Aid | ChloraPrep UK Infection Prevention & Control
Surgical Sales Aid | ChloraPrep UK Infection Prevention & ControlSurgical Sales Aid | ChloraPrep UK Infection Prevention & Control
Surgical Sales Aid | ChloraPrep UK Infection Prevention & Control
 
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & Control
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & ControlDarouiche Clinical Summary | ChloraPrep UK Infection Prevention & Control
Darouiche Clinical Summary | ChloraPrep UK Infection Prevention & Control
 
Fumigation process and hospital infection control
Fumigation process and hospital infection controlFumigation process and hospital infection control
Fumigation process and hospital infection control
 
Plaq_Dipho_EN_2014_HD
Plaq_Dipho_EN_2014_HDPlaq_Dipho_EN_2014_HD
Plaq_Dipho_EN_2014_HD
 
Industrial Pharmacy I -Ophthalmic preparation part 1
 Industrial Pharmacy I -Ophthalmic preparation part 1 Industrial Pharmacy I -Ophthalmic preparation part 1
Industrial Pharmacy I -Ophthalmic preparation part 1
 
OP & OT sterilisation during COVID Times
OP & OT sterilisation during COVID TimesOP & OT sterilisation during COVID Times
OP & OT sterilisation during COVID Times
 
Materials for disinfecting the pulp space
Materials for disinfecting the pulp spaceMaterials for disinfecting the pulp space
Materials for disinfecting the pulp space
 
Sterilisation ppt ashitha
Sterilisation ppt ashithaSterilisation ppt ashitha
Sterilisation ppt ashitha
 
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & Control
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & ControlMadeo Clinical Summary | ChloraPrep UK Infection Prevention & Control
Madeo Clinical Summary | ChloraPrep UK Infection Prevention & Control
 
Disinfectants- Pharmaceutical Microbiology
Disinfectants- Pharmaceutical MicrobiologyDisinfectants- Pharmaceutical Microbiology
Disinfectants- Pharmaceutical Microbiology
 
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]
Infection Control Guidelines for Ophthalmology Clinic [compatibility mode]
 
Surgical skin antiseptics
Surgical skin antisepticsSurgical skin antiseptics
Surgical skin antiseptics
 
Ocular theraputics
Ocular theraputicsOcular theraputics
Ocular theraputics
 
Sterilization_and_Disinfection.pptx
Sterilization_and_Disinfection.pptxSterilization_and_Disinfection.pptx
Sterilization_and_Disinfection.pptx
 
Disinfection control in Prosthodontics
Disinfection control in ProsthodonticsDisinfection control in Prosthodontics
Disinfection control in Prosthodontics
 
ocular drug delivery system
ocular drug delivery systemocular drug delivery system
ocular drug delivery system
 
Dyes.pptx
Dyes.pptxDyes.pptx
Dyes.pptx
 
Vital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptxVital dyes and stains Used in Ophthalmic Practice.pptx
Vital dyes and stains Used in Ophthalmic Practice.pptx
 
Fungal keratitis
Fungal keratitisFungal keratitis
Fungal keratitis
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery system
 

Último

MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 

Último (20)

MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 

Surgical Leave Piece | ChloraPrep UK Infection Prevention & Control

  • 1. “Whilst every person carries millions of bacteria on their skin, hospitals should not be tolerant of any infections that could be avoided” The Public Accounts Committee, 10th November 20091 Prescribing information can be found on the back cover
  • 2. “In most SSIs, the source of pathogens is the endogenous flora of the patient’s skin”2 SSIs are 1 in 7 of all hospital-acquired infections are SSIs1 serious SSIs require an average additional stay of 6.5 days and costly and hospital costs are doubled3 Patients with SSIs are 60% more likely to spend time in ICU, 5 times more likely to be readmitted to hospital and twice as likely to die4 Health-related quality of life may be significantly impaired5 At one London Trust, the annual cost associated with SSIs for just one surgical core area (coronary artery bypass graft) amounted to around £500,0006 Surveillance programmes that rely only on inpatient data may hugely underestimate the incidence and cost of SSIs7,8
  • 3. ChloraPrep reduced SSIs by 41% compared with povidone iodine scrub and paint9 20 p=0.004 Incidence of SSIs in 15 clean- 16.1 contaminated 10 surgery 5 9.5 (% patients)9 0 Povidone iodine ChloraPrep n=440 n=409 ChloraPrep was significantly more protective against both superficial (52% reduction) and deep incisional infections (67% reduction):9 10 p=0.008 Incidence of incisional 8 infections 8.6 6 (% patients)9 4 p=0.05 4.2 2 3.0 1.0 0 Povidone iodine Superficial incisional Deep incisional n=440 infection infection ChloraPrep n=409 The number needed to treat with ChloraPrep instead of povidone iodine in order to prevent one case of SSI was approximately 179
  • 4. ChloraPrep was significantly more effective than 0.5% chlorhexidine/70% isopropyl alcohol10 Dressings removed 24 hours after saphenectomy contained a significantly lower number of micro-organisms with ChloraPrep10 20 Mean p=0.007 CFU counts 15 24 hours 10 14.8 after surgery10 p=0.02 5 0.6 4.2 0.4 0 0.5% chlorhexidine/ Adhesive dressing Absorbent dressing 70% isopropyl component component alcohol n=24 ChloraPrep n=22 Rates of SSI following saphenous vein harvest as high as 1 in 5 patients have been reported10 At 30 days post-discharge, no ChloraPrep patient had developed an SSI following saphenectomy10 25 Incidence of p=0.0502 superficial 20 SSI post- 20.8 discharge 15 (% patients)10 10 5 0 0 0.5% chlorhexidine/ ChloraPrep 70% isopropyl alcohol n=22 n=24
  • 5. ChloraPrep provides broad spectrum, rapid, residual and persistent antimicrobial activity ChloraPrep is effective against a broad range of micro-organisms including MRSA, VRE, Clostridium difficile, coagulase negative staphylococci and most viruses and fungi11-13 Optimal agent ChloraPrep for pre-surgical skin antisepsis12 Rapid ChloraPrep has good activity levels within 30 seconds;14 povidone iodine takes 2-3 minutes to reach full effect11 Persistent ChloraPrep is effective for at least 48 hours.14,15 0.5% chlorhexidine13 and iodophors have been shown to have a much shorter duration of activity16 Practical Unlike povidone iodine, ChloraPrep is not inactivated in the presence of blood12
  • 6. ChloraPrep is an easy to apply, sterile, skin antisepsis system ChloraPrep is the only 2% chlorhexidine / 70% isopropyl alcohol licensed for cutaneous antisepsis prior to invasive procedures in the UK17 Sterile solution is maintained in a glass ampoule prior to activation, obviating concerns about contamination18 In line with ANTT™, the operator’s hands do not come into contact with the patient’s skin, preventing cross contamination18 The foam sponge controls flow to prevent splashing/pooling while gently helping to expose bacteria in the lower cell layers A back and forth prep was used in all the phase III efficacy studies of ChloraPrep applicators19
  • 7. Using ChloraPrep surgical applicators 1. Pinch 2. Apply 3. Dry Pinch the lever to release the Starting at the incision site, Leave the area to dry solution. You will hear a ‘pop’ gently press the applicator completely before applying as the ampoule breaks. against the skin until the sterile drapes. Do not blot solution soaks the sponge. or wipe away. Discard the applicator after a single use. Apply using repeated up and down, back and forth strokes Important safety point: for at least 30 seconds, before Do not drape or use ignition working outwards towards the source until the solution has periphery. completely dried. The 26ml applicator contains two swabs. Where applicable, the swabs can be moistened by pressing against the soaked sponge and then used to clean the umbilicus. References: 1. House of Commons Public Accounts Committee. Reducing Healthcare Associated Infection in Hospitals in England.10 November 2009. London: The Stationery Office Limited. 2. Murkin CE. Br J Nurs 2009; 18: 665-9. 3. Edwards PS et al. Cochrane DB Syst Rev 2008. DOI:10.1002/14651858.CD003949.pub2. 4. Kirkland KB et al. Infect Control Hosp Epidemiol 1999; 20: 725-30. 5. Whitehouse JD et al. Infect Control Hosp Epidemiol 2002; 23: 183-9. 6. Frampton L. Clin Services J 2008; June edition. 7. Tanner J et al. J Hosp Infect 2009; 72: 243-50. 8. Ward VP et al. J Hosp Infect 2008; 70: 166-73. 9. Darouiche R et al. New Engl J Med 2010; 362: 18-26. 10. Casey AL et al. Poster presented at ECCMID, Barcelona, Spain, April 2008 11. Crosby CT, Mares AK. J Vasc Access Devices 2001; Spring: 26-31. 12. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61 13. Data on file, CareFusion Ltd. 14. Hibbard JS. J Infus Nurs 2005; 28: 194-207. 15. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418. 16. Fletcher N et al. J Bone Joint Surg Am 2007; 89: 1605-18. 17. UK PL 31760/0001. 18. McDonald CP. Vox Sanguinis 2001; 80: 135-41. 19. Richardson D. J Assoc Vasc Access 2006; 11: 215-21.
  • 8. Range of surgical applicators Licensed, sterile, single use, ANTT™, latex free applicators available in the UK Coverage area: 15 cm x 15 cm 3ml NHS list price per applicator: £0.85 (ex. VAT and delivery) clear NHS supply chain order code: MRB306 Coverage area: 25 cm x 30 cm 10.5ml NHS list price per applicator: £2.92 (ex. VAT and delivery) clear NHS supply chain order code: MRB304 Coverage area: 50 cm x 50 cm 26ml NHS list price per applicator: £6.50 (ex. VAT and delivery) clear NHS supply chain order code: MRB305 Coverage area: 15 cm x 15 cm 3ml NHS list price per applicator: £0.89 (ex. VAT and delivery) tinted NHS supply chain order code: MRB494 Coverage area: 25 cm x 30 cm 10.5ml NHS list price per applicator: £3.07 (ex. VAT and delivery) tinted NHS supply chain order code: MRB495 Coverage area: 50 cm x 50 cm 26ml NHS list price per applicator: £6.83 (ex. VAT and delivery) tinted NHS supply chain order code: MRB496 For customer services and all other enquiries: Please telephone: 0800 0437 546 Email: enquiries@chloraprep.co.uk or visit: www.chloraprep.co.uk Prescribing Information only on intact skin. Avoid contact with eyes, mucous membranes, middle ear ChloraPrep® (PL31760/0002) & ChloraPrep with Tint (PL31760-0001) 2% and neural tissue. Should not be used in children under 2 months of age. chlorhexidine gluconate w/v / 70% isopropyl alcohol v/v cutaneous solution. Solution is flammable. Do not use with ignition sources until dry, do not allow Indication: Disinfection of skin prior to invasive medical procedures. to pool, and remove soaked materials before use. Over-vigorous use on Dosage & administration: ChloraPrep – 0.67ml, 1.5ml, 3ml, 10.5ml, 26ml; fragile or sensitive skin or repeated use may lead to local skin reactions. At ChloraPrep with Tint – 3ml, 10.5ml, 26ml. Volume dependent on invasive the first sign of local skin reaction, application should be stopped. Per procedure being undertaken. Applicator squeezed to break ampoule and applicator costs (ex VAT) ChloraPrep – 0.67ml (SEPP) - 30p; 1.5ml (FREPP) release antiseptic solution onto sponge. Solution applied by gently pressing - 55p; 3ml - 85p; 10.5ml - £2.92; 26ml - £6.50. ChloraPrep with Tint – 3ml - sponge against skin and moving back and forth for 30 seconds. The area 89p; 10.5ml - £3.07; 26ml - £6.83. Legal category: GSL. Marketing covered should be allowed to air dry. Side effects, precautions & Authorisation Holder: CareFusion UK 244 Ltd, 43 London Road, Reigate, contra-indications: Very rarely allergic or skin reactions reported with Surrey RH2 9PW, UK. Date of preparation: July 2010. chlorhexidine, isopropyl alcohol and Sunset Yellow. Contra-indicated for patients with known hypersensitivity to these constituents. For external use CHL104a Date of preparation: August 2010